ClinicalTrials.govpublic full text
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
cardiovascular disease, peripheral arterial disease, diabetes mellitus, coronary heart disease, stroke, cholesterol, hdl cholesterol, simvastatin, ezetimibe, er niacin, laropiprant, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 893993
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.